Literature DB >> 15669684

Successful long-term treatment of hepatic carnitine palmitoyltransferase I deficiency and a novel mutation.

J M Stoler1, M A Sabry, C Hanley, C L Hoppel, V E Shih.   

Abstract

Individuals with carnitine palmitoyltransferase I (CPT-I) deficiency cannot metabolize long-chain fatty acids and can develop life-threatening hypoglycaemia. We present a boy with CPT-I deficiency maintained on a very low-fat diet with nighttime uncooked cornstarch feedings for 5(1/2) years with good success. He has had normal growth and no episodes of hypoglycaemia or adverse side-effects. We found that he was homozygous for a previously undescribed mutation, T314I, in the CPT1A protein.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15669684     DOI: 10.1023/b:boli.0000042979.42120.55

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  20 in total

1.  Molecular and enzymatic characterization of a unique carnitine palmitoyltransferase 1A mutation in the Hutterite community.

Authors:  C Prip-Buus; L Thuillier; N Abadi; C Prasad; L Dilling; J Klasing; F Demaugre; C R Greenberg; J C Haworth; V Droin; N Kadhom; S Gobin; P Kamoun; J Girard; J P Bonnefont
Journal:  Mol Genet Metab       Date:  2001-05       Impact factor: 4.797

2.  Molecular characterization of L-CPT I deficiency in six patients: insights into function of the native enzyme.

Authors:  N F Brown; R S Mullur; I Subramanian; V Esser; M J Bennett; J M Saudubray; A S Feigenbaum; J A Kobari; P M Macleod; J D McGarry; J C Cohen
Journal:  J Lipid Res       Date:  2001-07       Impact factor: 5.922

3.  Brief report: renal tubular acidosis in carnitine palmitoyltransferase type 1 deficiency.

Authors:  Z C Falik-Borenstein; S C Jordan; J M Saudubray; M Brivet; F Demaugre; J Edmond; S D Cederbaum
Journal:  N Engl J Med       Date:  1992-07-02       Impact factor: 91.245

4.  Fine chromosome mapping of the genes for human liver and muscle carnitine palmitoyltransferase I (CPT1A and CPT1B).

Authors:  C H Britton; D W Mackey; V Esser; D W Foster; D K Burns; D P Yarnall; P Froguel; J D McGarry
Journal:  Genomics       Date:  1997-02-15       Impact factor: 5.736

5.  Carnitine palmityltransferase. Location of two enzymatic activities in rat liver mitochondria.

Authors:  C L Hoppel; R J Tomec
Journal:  J Biol Chem       Date:  1972-02-10       Impact factor: 5.157

6.  Fasting hypoglycemia resulting from hepatic carnitine palmitoyl transferase deficiency.

Authors:  P F Bougnères; J M Saudubray; C Marsac; O Bernard; M Odièvre; J Girard
Journal:  J Pediatr       Date:  1981-05       Impact factor: 4.406

7.  Uncooked cornstarch--efficacy in type I glycogenosis.

Authors:  P J Lee; M A Dixon; J V Leonard
Journal:  Arch Dis Child       Date:  1996-06       Impact factor: 3.791

Review 8.  Carnitine palmitoyltransferase deficiencies.

Authors:  J P Bonnefont; F Demaugre; C Prip-Buus; J M Saudubray; M Brivet; N Abadi; L Thuillier
Journal:  Mol Genet Metab       Date:  1999-12       Impact factor: 4.797

9.  Atypical features of the hepatic form of carnitine palmitoyltransferase deficiency in a Hutterite family.

Authors:  J C Haworth; F Demaugre; F A Booth; L A Dilling; S P Moroz; S S Seshia; L E Seargeant; P M Coates
Journal:  J Pediatr       Date:  1992-10       Impact factor: 4.406

10.  Characterisation of carnitine palmitoyltransferases in patients with a carnitine palmitoyltransferase deficiency: implications for diagnosis and therapy.

Authors:  J Schaefer; S Jackson; F Taroni; P Swift; D M Turnbull
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-02       Impact factor: 10.154

View more
  4 in total

1.  Normal Levels of Plasma Free Carnitine and Acylcarnitines in Follow-Up Samples from a Presymptomatic Case of Carnitine Palmitoyl Transferase 1 (CPT1) Deficiency Detected Through Newborn Screening in Denmark.

Authors:  Luise Borch; Allan Meldgaard Lund; Flemming Wibrand; Ernst Christensen; Charlotte Søndergaard; Birthe Gahrn; David Michael Hougaard; Brage Storstein Andresen; Niels Gregersen; Rikke Katrine Jentoft Olsen
Journal:  JIMD Rep       Date:  2011-09-22

Review 2.  Disorders of carnitine transport and the carnitine cycle.

Authors:  Nicola Longo; Cristina Amat di San Filippo; Marzia Pasquali
Journal:  Am J Med Genet C Semin Med Genet       Date:  2006-05-15       Impact factor: 3.908

3.  Selective reversible inhibition of liver carnitine palmitoyl-transferase 1 by teglicar reduces gluconeogenesis and improves glucose homeostasis.

Authors:  Roberto Conti; Edoardo Mannucci; Pompeo Pessotto; Emanuela Tassoni; Paolo Carminati; Fabio Giannessi; Arduino Arduini
Journal:  Diabetes       Date:  2011-02       Impact factor: 9.461

Review 4.  Combined defects in oxidative phosphorylation and fatty acid β-oxidation in mitochondrial disease.

Authors:  Abena Nsiah-Sefaa; Matthew McKenzie
Journal:  Biosci Rep       Date:  2016-02-02       Impact factor: 3.840

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.